慢性阻塞性肺病中的免疫和炎症:系统性审查
Fabíola Ramos Jesus1,2, Fabine Correia Passos2, Michelle Miranda Lopes Falcão3
1Maternidade Climério de Oliveira (MCO/EBSERH), Universidade Federal da Bahia, Salvador 40055-150, Bahia, Brazil.
Journal of clinical medicine
|June 27, 2024
概括
慢性阻塞性肺病 (COPD) 加快了衰老过程,显示出炎症增加和免疫系统衰退. 这一审查证实了COPD患者的加速免疫发生,强调了对其肺功能影响的进一步研究的需要.
科学领域:
- 免疫学 免疫学 免疫学
- 老年学是指老年学的学科.
- 肺部病理学 肺部病理学
背景情况:
- 慢性阻塞性肺病 (COPD) 与过早衰老和全身炎症有关.
- 了解COPD的免疫发生对于疾病管理至关重要.
研究的目的:
- 系统地审查COPD中的免疫和炎症标志物.
- 分析COPD患者的T细胞子集和端粒长度.
主要方法:
- 系统审查PubMed,科学直播,斯科普斯,科克兰图书馆和科学网.
- 包括15项观察性研究,将COPD患者与对照组进行比较.
- 评估炎症,衰老标志物,T细胞 (原始,记忆,CD28null) 和白细胞端粒长度.
主要成果:
- 慢性慢性肺炎的加速免疫发生,其特征是增加IL-6,端粒缩短,以及高CD28null T细胞.
- 肺功能严重程度对免疫衰变的影响尚不清楚.
- 15项研究中有8项被评为高质量研究.
结论:
- 稳定的COPD患者表现出加速免疫和全身炎症.
- 需要进一步的研究来澄清COPD中免疫和肺功能之间的关系.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Drugs Used in Lower Respiratory Disorders: Overview
402
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
402
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


